Actively Recruiting
Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)
Led by The Second Affiliated Hospital of Hainan Medical University · Updated on 2025-02-13
3000
Participants Needed
1
Research Sites
280 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Aim to observe the application of MR-Linac for precision radiotherapy of tumours, analyse its therapeutic effect, toxic and side effects,Characteristics of dosimetric parameters etc.
CONDITIONS
Official Title
Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing or who have undergone imaging or treatment with MR-Linac
- Age between 18 and 75 years, any gender
- ECOG performance status score of 0 to 2
- Life expectancy longer than 6 months
- Able to provide written informed consent
You will not qualify if you...
- Contraindications to MRI such as claustrophobia or incompatible metallic/electronic implants
- Severe comorbid conditions preventing toleration or completion of radiotherapy as judged by investigator
- Acute inflammatory diseases that require systemic therapy
- Active infectious diseases
- Pregnant or nursing women, or planning pregnancy during the study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Second Affiliated Hospital of Hainan Medical University
Haikou, China, 570311
Actively Recruiting
Research Team
J
junnv xu, doctor
CONTACT
Y
yuecan zeng, doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here